Clinical Trial Update: Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating para-tyrosine supplementation in sepsis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Para-Tyrosine (para-tyrosine)

Snippet

Sponsor: University of Pecs | Conditions: Sepsis | Phase 2 | Status: SUSPENDED